Content deleted Content added
No edit summary |
No edit summary |
||
| Line 35: | Line 35: | ||
'''5F-PB-22''' or '''Quinolin-8-yl 1-pentyfluoro-1''H''-indole-3-8-carboxylate''' is a [[designer drug]] which acts as a [[cannabinoid agonist]].<ref>{{cite DOI|10.1021/acschemneuro.5b00107}}</ref> The structure of 5F-PB-22 appears to have been designed with an understanding of [[structure-activity relationship]]s within the indole class of cannabinoids.<ref>{{cite web | url=http://forendex.southernforensic.org/index.php/detail/index/1233 | title=5F-PB-22 | publisher=Forendex | accessdate=24 June 2015}}</ref> |
'''5F-PB-22''' or '''Quinolin-8-yl 1-pentyfluoro-1''H''-indole-3-8-carboxylate''' is a [[designer drug]] which acts as a [[cannabinoid agonist]].<ref>{{cite DOI|10.1021/acschemneuro.5b00107}}</ref> The structure of 5F-PB-22 appears to have been designed with an understanding of [[structure-activity relationship]]s within the indole class of cannabinoids.<ref>{{cite web | url=http://forendex.southernforensic.org/index.php/detail/index/1233 | title=5F-PB-22 | publisher=Forendex | accessdate=24 June 2015}}</ref> |
||
In January 2014, 5F-PB-22 was designated as a [[Schedule I controlled substance]] in the United States after several deaths were associated with its use.<ref name=pmid24876364>{{Cite pmid|24876364}}</ref> |
In January 2014, 5F-PB-22 was designated as a [[Schedule I controlled substance]] in the United States after several deaths were associated with its use.<ref name=pmid24876364>{{Cite pmid|24876364}}</ref><ref>{{cite journal | url=http://www.nejm.org/doi/full/10.1056/NEJMp1505328 | title=Synthetic Cannabinoid–Related Illnesses and Deaths | author=Jordan Trecki, Roy R. Gerona, Michael D. Schwartz | journal=New England Journal of Medicine | year=2015 | month=July | volume=373 | issue=2 | pages=103-107 | doi=10.1056/NEJMp1505328 | pmid=26154784}}</ref> |
||
Revision as of 12:14, 11 July 2015
 | |
| Legal status | |
|---|---|
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| ChemSpider | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C23H21FN2O2 |
| Molar mass | 376.42 g/mol g·mol−1 |
| 3D model (JSmol) | |
| |
| |
5F-PB-22 or Quinolin-8-yl 1-pentyfluoro-1H-indole-3-8-carboxylate is a designer drug which acts as a cannabinoid agonist.[1] The structure of 5F-PB-22 appears to have been designed with an understanding of structure-activity relationships within the indole class of cannabinoids.[2]
In January 2014, 5F-PB-22 was designated as a Schedule I controlled substance in the United States after several deaths were associated with its use.[3][4]
See also
References
- ^ Template:Cite DOI
- ^ "5F-PB-22". Forendex. Retrieved 24 June 2015.
- ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 24876364, please use {{cite journal}} with
|pmid=24876364instead. - ^ Jordan Trecki, Roy R. Gerona, Michael D. Schwartz (2015). "Synthetic Cannabinoid–Related Illnesses and Deaths". New England Journal of Medicine. 373 (2): 103–107. doi:10.1056/NEJMp1505328. PMID 26154784.
{{cite journal}}: Unknown parameter|month=ignored (help)CS1 maint: multiple names: authors list (link)